The nerve root block or selective nerve root block is one of the primarily preoperative diagnostic tool to identify and confirm the lesion site of primary cause of pain and that is considered as one component of a comprehensive treatment program. The purpose of our study is to evaluate the effect and duration of the pain control by selective spinal nerve root block as a conservative treatment in patients presenting with chronic or recurrent sciatica. The authors performed 95 selective nerve root blocks in 72 patients from Sep. 1994 to May. 1996, (mean follow up 11.6 month) at the department of orthopedic surgery, Kosin University Gospel Hospital, and the results were as follows: 1. Among 72 cases, spinal stenosis was in 45 cases (62.5%), HIVD in 19 cases (26.4%), failed back syndrome in 5 cases (6.9%), spondylosis in 2 cases (2.8%), and spondylolisthesis in I case (1.4%). 2. In 72 cases, improved more than 50% of sciatica were 61 cases (84.7%) at 3 hours, 53 cases (73.6%) at I week, 35 cases (48.6%) at 1 month, 33 cases (45.8%) at 3 months, and 33 cases (45.8%) at 6 months respectively. 3. At last follow-up, excellent and good results were 35 cases (48.6%), fair results were 25 cases (34.7%) and poor results were 12 cases (16.7%) by the Kirkaldy-Willis criteria. 4. Complications were 1 case of transient hypotension, 2 cases of severe paresthesia, but subsided without residual complication. Therefore, the selective nerve root block is one of the valuable procedure that is helpful and extremely safe in useful treatment for radicular pain associated with lumbar disease. And the trial of selective nerve root block was recommended before deciding surgical intervention on an outpatient basis.
Follow-Up Studies ; Humans ; Hypotension ; Orthopedics ; Outpatients ; Paresthesia ; Sciatica* ; Spinal Nerve Roots* ; Spinal Nerves* ; Spinal Stenosis ; Spondylolisthesis ; Spondylosis

No abstract available.
Adenomyosis* ; Humans ; Uterus*

No abstract available.
Adenomyosis* ; Humans ; Uterus*

No abstract available.
Adenoids* ; Carcinoma, Adenoid Cystic* ; Maxillary Sinus*

No abstract available.
Galactitol* ; Galactosemias* ; Humans ; Infant* ; Mass Screening*

Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is considered to be a severe form of preeclampsia. Preeclampsia is a multi system disease of pregnancy associated with a significant impact on health for both mother and fetus. Despite the voluminous literature, the diagnosis and management of this syndrome remain controversial and it is ultimately treated by delivery. Treatment of HELLP syndrome usually is supportive management, including seizure prophylaxis and blood pressure control and treatment of complications. However, several clinical trials have suggested that corticosteroids can stabilize the disease in the antepartum period and accelerate recovery after delivery. Rarely, some patients require transfusion of blood products and plasmapheresis. This articles focuses on the diagnosis, management of HELLP syndrome based on results of recent studies
Adrenal Cortex Hormones ; Blood Platelets ; Blood Pressure ; Female ; Fetus ; HELLP Syndrome ; Hemolysis ; Humans ; Liver ; Mothers ; Plasmapheresis ; Pre-Eclampsia ; Pregnancy ; Seizures

Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is considered to be a severe form of preeclampsia. Preeclampsia is a multi system disease of pregnancy associated with a significant impact on health for both mother and fetus. Despite the voluminous literature, the diagnosis and management of this syndrome remain controversial and it is ultimately treated by delivery. Treatment of HELLP syndrome usually is supportive management, including seizure prophylaxis and blood pressure control and treatment of complications. However, several clinical trials have suggested that corticosteroids can stabilize the disease in the antepartum period and accelerate recovery after delivery. Rarely, some patients require transfusion of blood products and plasmapheresis. This articles focuses on the diagnosis, management of HELLP syndrome based on results of recent studies
Adrenal Cortex Hormones ; Blood Platelets ; Blood Pressure ; Female ; Fetus ; HELLP Syndrome ; Hemolysis ; Humans ; Liver ; Mothers ; Plasmapheresis ; Pre-Eclampsia ; Pregnancy ; Seizures

No abstract available.
Cell Line, Tumor* ; Gonadal Steroid Hormones* ; Gonadotropin-Releasing Hormone* ; Gonads*

OBJECTIVE: The ovine fetus responds to hemorrhage with a 10-20 fold increase in plasma erythropoietin (EPO) concentration at 24 hr and a return toward normal at 48 hr after the hemorrhage. The objective of the present study was more accurately to compare the magnitude and time course of the plasma EPO response after fetal hemorrhage. METHODS: Chronically catheterized, 12 of late gestation ovine fetus were gradually hemorrhaged 40% of their blood volume over 2 hr (1ml/min). Plasma was sampled for EPO concentration at 1, 2, 3, 4, 6, 8, 10, 12, 16, 20, 24, 30, 36 hr after initiating the hemorrhage were collected at these times. Radioimmunoassay was used to measure plasma EPO concentrations. Analysis of variance was used for statistical analysis. RESULT: After a slow hemorrhage in the ovine fetus (1ml/min over 2hr), plasma EPO concentration increased significantly at 4hr (2.3 times basal values), reached a maximum at 16 hr (33.3 times basal values), and declined thereafter. CONCLUSION: We studied change in time course of the fetal plasma EPO after slow hemorrhage and recent studies have shown that the fetal kidney, liver and placenta express EPO mRNA. These observation suggest that plasma EPO increase may be mediated by a tissue specific up-regulation of EPO transcription in the fetal kidney, liver and placenta. We have studied change in Epo mRNA expression in various fetal tissue after slow haemorrhage.
Blood Volume ; Catheters ; Erythropoietin* ; Fetus ; Hemorrhage* ; Kidney ; Liver ; Placenta ; Plasma* ; Pregnancy ; Radioimmunoassay ; RNA, Messenger ; Sheep ; Up-Regulation

No abstract available.